Thermo Fisher Scientific has reportedly agreed to purchase Life Technologies Corp. for $13.6 billion in a deal expected to close in early 2014. Waltham, Massachusetts-based Thermo Fisher has apparently offered Life Technologies’ shareholders $76 for each of their shares and will assume some $2.2 billion in debt. Life Technologies, located in California, makes more than 50,000 different types of scientific equipment, including gene-sequencing and DNA-analysis machines. According to a news source, it reported $3.8 billion in revenue in 2012. The deal will allow Thermo Fisher to expand its market share in the manufacture of genetic-sequencing machines, a high-growth industry in the new era of personalized medicine. Thermo Fisher CEO Marc Casper said, “The acquisition of Life Technologies enhances all three elements of our growth strategy: technological innovation, a unique customer value proposition and expansion in emerging markets.” See The New York Times DealBook, April 15, 2013.